Dogwood Therapeutics Inc. (DWTX)
NASDAQ: DWTX
· Real-Time Price · USD
4.82
-0.08 (-1.63%)
At close: Sep 18, 2025, 3:59 PM
4.85
0.62%
After-hours: Sep 18, 2025, 05:48 PM EDT
Dogwood Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 17.26K | 17.02K | 12.18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -17.26K | -17.02K | -12.18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -3.92M | -4.43M | -7.54M | -2.3M | -1.07M | -1.31M | -1.14M | -1.27M | -1.48M | -1.56M | -2.09M | -2.59M | -3.67M | -3.96M | -4.19M | -4.11M | -4.28M | -3.06M |
Interest Income | 111.38K | n/a | n/a | 20.49K | 19.99K | 22.77K | 34.95K | 39.22K | 36.31K | 40.42K | n/a | 16.61K | 4.8K | 906.00 | n/a | 1.51K | 1.5K | 1.4K |
Pretax Income | -3.81M | -10.73M | -7.73M | -2.28M | -1.05M | -1.29M | -1.1M | -1.24M | -1.44M | -1.52M | -2.04M | -2.58M | -3.67M | -3.96M | -4.51M | -4.11M | -4.28M | -3.06M |
Net Income | -3.81M | -10.92M | -7.73M | -2.28M | -1.05M | -1.29M | -1.1M | -1.24M | -1.44M | -1.52M | -2.04M | -2.58M | -3.67M | -3.96M | -4.51M | -4.11M | -4.28M | -3.06M |
Selling & General & Admin | 1.35M | 1.98M | 5.23M | 1.77M | 733.74K | 970.38K | 839.8K | 900.09K | 919.37K | 1.06M | 818K | 969.95K | 1.27M | 1.19M | 1.27M | 1.15M | 1.08M | 1.35M |
Research & Development | 2.57M | 2.44M | 2.32M | 535.16K | 336.08K | 343.72K | 298.32K | 374.2K | 557.84K | 497.71K | 1.27M | 1.62M | 2.41M | 2.77M | 2.92M | 2.96M | 3.21M | 1.71M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.92M | 4.41M | 7.54M | 2.3M | 1.07M | 1.31M | 1.14M | 1.27M | 1.48M | 1.56M | 2.09M | 2.59M | 3.67M | 3.96M | 4.19M | 4.11M | 4.28M | 3.06M |
Interest Expense | n/a | 147.09K | 155.44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.92M | -4.43M | 7.54M | 2.3M | 1.07M | 1.31M | 1.14M | 1.27M | 1.48M | 1.56M | 2.09M | 2.59M | 3.67M | 3.96M | 4.19M | 4.11M | 4.28M | 3.06M |
Income Tax Expense | 149.00 | 190.54K | -503 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.91M | 1.44M | 1.31M | 1.11M | 916.03K | 770.32K | 770.32K | 763.75K | 736.46K | 733.22K | 733.22K | 368K | 333.21K | 333.21K | 333.21K | 333.21K | 333.21K | 333.04K |
Shares Outstanding (Diluted) | 1.91M | 1.44M | 1.31M | 1.11M | 916.03K | 770.32K | 770.32K | 763.75K | 736.46K | 733.22K | 733.22K | 368K | 333.21K | 333.21K | 333.21K | 333.21K | 333.21K | 333.04K |
EPS (Basic) | -1.99 | -8.45 | -5.9 | -2.05 | -1.15 | -1.68 | -1.43 | -1.62 | -1.96 | -2.07 | -2.79 | -7 | -11.01 | -11.89 | -13.54 | -12.33 | -12.85 | -9.18 |
EPS (Diluted) | -1.99 | -8.45 | -5.9 | -2.05 | -1.15 | -1.68 | -1.43 | -1.62 | -1.96 | -2.07 | -2.79 | -7 | -11.01 | -11.89 | -13.54 | -12.33 | -12.85 | -9.18 |
EBITDA | -3.79M | -10.57M | -7.57M | -2.3M | -1.07M | -1.31M | -1.14M | -1.27M | -1.48M | -1.56M | -2.09M | -2.59M | -3.67M | -3.96M | -4.19M | -4.11M | -4.28M | -3.06M |
EBIT | -3.81M | -10.59M | -7.57M | -2.3M | -1.07M | -1.31M | -1.14M | -1.27M | -1.48M | -1.56M | -2.09M | -2.59M | -3.67M | -3.96M | -4.19M | -4.11M | -4.28M | -3.06M |
Depreciation & Amortization | 17.26K | 17.02K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |